Novavax (NVAX) stock forecast for 2022. Forecast tables and graphs.

Novavax (NVAX) stock forecast for 2022

The forecast has been updated: June 24, 2021 12:20


Novavax stock price online today

Analyst Target Price

258

Dividend Date

10.05.2019

Ex Dividend Date

-

Last Split Factor

1:20

Last Split Date

10.05.2019

Should you buy or sell Novavax stock stock today? What is the projected target price level for 2022? How much will it cost in 2022? Novavax stock Stock Monthly Prediction for January, February, March, April, May, July, July, August, September, October, November and December 2022.

We predict the dynamics of the stock market value using resonant artificial intelligence systems.

Technical, fundamental analyzes, news background, general geopolitical situation in the world and other factors are taken into account.

Forecasts are adjusted once a day taking into account the price change of the previous day.

To date, analysts have a $258 target price for Novavax stock stock.

Today 200 Day Moving Average is the resistance level (181.6468 $).

50 Day Moving Average is the support level (166.6097 $).




NVAX Forecast for 2022

Month Rate Forecast MIN Rate MAX Rate Volati-
lity, %
Jan 218.86 184.71 240.52 23.20 %
Feb 243.81 215.28 293.54 26.66 %
Mar 263.55 231.93 299.92 22.67 %
Apr 229.56 206.83 261.23 20.83 %
May 188.92 177.59 208.76 14.93 %
Jun 180.99 146.78 205.97 28.73 %
Jul 206.51 163.14 230.67 29.27 %
Aug 192.26 158.23 227.44 30.43 %
Sep 188.22 148.70 210.81 29.46 %
Oct 191.05 150.35 222.57 32.45 %
Nov 215.12 178.98 241.58 25.91 %
Dec 226.09 186.75 270.18 30.88 %

The forecasts table above shows the forecast values of the company's stock price for each month. The Rate Forecast column displays the Optimal Average Forecast Price. The MIN Rate column displays a pessimistic forecast for this month. “MAX Rate” is an optimistic forecast. The % Volatility column represents the approximate monthly volatility of Novavax stock.


Novavax overview

Novavax Address

20 FIRSTFIELD ROAD, GAITHERSBURG, MD, US

Market Capitalization

13 994 209 280 $

EBITDA

-157 414 000

PE Ratio

None

PEG Ratio

0

Dividend Per Share

None

Dividend Yield

0

EPS

-8.597

Quarterly Earnings Growth YOY

0

Quarterly Revenue Growth YOY

131.434

Trailing PE

0

Forward PE

28.4091

EV To Revenue

12.3827

EV To EBITDA

0

52 Week High

331.68

52 Week Low

70.3104

50 Day Moving Average

166.6097

200 Day Moving Average

181.6468

Shares Outstanding

74094400

Shares Float

73339861

Shares Short Prior Month

5237741

Short Ratio

1.45

Percent Insiders

0.553

Percent Institutions

58.232

Novavax stock forecast for this year


Novavax stock forecast for Jan 2022.
Estimated Average Forecasted Novavax Price: 218.86. Negative monthly dynamics of the instrument is expected with 23.203% volatility is expected.

Pessimistic forecast: 184.71

Optimistic: 240.52


Novavax stock forecast for Feb 2022.
Estimated Average Forecasted Novavax Price: 243.81. Positive monthly dynamics of the instrument is expected with 26.661% volatility is expected.

Pessimistic forecast: 215.28

Optimistic: 293.54


Novavax stock forecast for Mar 2022.
Estimated Average Forecasted Novavax Price: 263.55. Positive monthly dynamics of the instrument is expected with 22.671% volatility is expected.

Pessimistic forecast: 231.93

Optimistic: 299.92


Novavax stock forecast for Apr 2022.
Estimated Average Forecasted Novavax Price: 229.56. Negative monthly dynamics of the instrument is expected with 20.826% volatility is expected.

Pessimistic forecast: 206.83

Optimistic: 261.23


Novavax stock forecast for May 2022.
Estimated Average Forecasted Novavax Price: 188.92. Negative monthly dynamics of the instrument is expected with 14.932% volatility is expected.

Pessimistic forecast: 177.59

Optimistic: 208.76


Novavax stock forecast for Jun 2022.
Estimated Average Forecasted Novavax Price: 180.99. Negative monthly dynamics of the instrument is expected with 28.735% volatility is expected.

Pessimistic forecast: 146.78

Optimistic: 205.97


Novavax stock forecast for Jul 2022.
Estimated Average Forecasted Novavax Price: 206.51. Positive monthly dynamics of the instrument is expected with 29.275% volatility is expected.

Pessimistic forecast: 163.14

Optimistic: 230.67


Novavax stock forecast for Aug 2022.
Estimated Average Forecasted Novavax Price: 192.26. Negative monthly dynamics of the instrument is expected with 30.431% volatility is expected.

Pessimistic forecast: 158.23

Optimistic: 227.44


Novavax stock forecast for Sep 2022.
Estimated Average Forecasted Novavax Price: 188.22. Negative monthly dynamics of the instrument is expected with 29.465% volatility is expected.

Pessimistic forecast: 148.70

Optimistic: 210.81


Novavax stock forecast for Oct 2022.
Estimated Average Forecasted Novavax Price: 191.05. Positive monthly dynamics of the instrument is expected with 32.446% volatility is expected.

Pessimistic forecast: 150.35

Optimistic: 222.57


Novavax stock forecast for Nov 2022.
Estimated Average Forecasted Novavax Price: 215.12. Positive monthly dynamics of the instrument is expected with 25.913% volatility is expected.

Pessimistic forecast: 178.98

Optimistic: 241.58


Novavax stock forecast for Dec 2022.
Estimated Average Forecasted Novavax Price: 226.09. Positive monthly dynamics of the instrument is expected with 30.879% volatility is expected.

Pessimistic forecast: 186.75

Optimistic: 270.18



Other Healthcare sector assets

Name Symbol Last Close Price Change
Abbott Laboratories
ABT 111.7 (24.06.2021) 0.78 %
AbbVie Inc.
ABBV 114.74 (24.06.2021) 0.65 %
Aeterna Zentaris Inc.
AEZS 0.9101 (23.06.2021) 4.01 %
Allakos Inc.
ALLK 91.24 (23.06.2021) 0.55 %
Allogene Therapeutics, Inc.
ALLO 23.49 (23.06.2021) -1.92 %
Amgen Inc.
AMGN 240.95 (24.06.2021) 0.94 %
Aphria Inc.
APHA 15.38 (07.05.2021) 0.00 %
Atara Biotherapeutics, Inc.
ATRA 15.5 (23.06.2021) -0.70 %
Aurora Cannabis Inc.
ACB 9.02 (23.06.2021) 1.23 %
Becton Dickinson and Company
BDX 239.82 (24.06.2021) -0.17 %
Biogen Inc.
BIIB 349.16 (24.06.2021) -6.11 %
Biohaven Pharmaceutical Holding Company Ltd.
BHVN 97.27 (24.06.2021) -0.46 %
BioNTech SE
BNTX 227.79 (24.06.2021) -0.75 %
bluebird bio, Inc.
BLUE 32.37 (23.06.2021) -1.25 %
Boston Scientific Corp.
BSX 43.71 (24.06.2021) -0.18 %
Bristol-Myers Squibb Company
BMY 65.85 (24.06.2021) 0.90 %
Canopy Growth Corp.
CGC 23.57 (23.06.2021) 0.86 %
Castle Biosciences, Inc.
CSTL 75.09 (24.06.2021) 0.55 %
Eli Lilly and Company
LLY 232.97 (24.06.2021) 7.31 %
Emergent BioSolutions Inc.
EBS 61.85 (24.06.2021) 3.00 %
Exelixis, Inc.
EXEL 22.86 (24.06.2021) 2.88 %
G1 Therapeutics, Inc.
GTHX 21.84 (23.06.2021) 2.25 %
Gilead Sciences, Inc.
GILD 66.65 (23.06.2021) -0.60 %
GlaxoSmithKline plc
GSK 39.85 (23.06.2021) 1.97 %
GoodRx Holdings, Inc.
GDRX 38.24 (23.06.2021) 1.30 %
GW Pharmaceuticals plc.
GWPH 218.96 (05.05.2021) 0.00 %
Incyte Corp.
INCY 86.13 (24.06.2021) 1.17 %
Inovio Pharmaceuticals, Inc.
INO 8.89 (24.06.2021) 2.30 %
Johnson & Johnson
JNJ 163.37 (24.06.2021) 0.46 %
Medtronic plc.
MDT 125.09 (24.06.2021) -0.32 %
Merck & Co., Inc.
MRK 76.36 (24.06.2021) 1.03 %
Moderna, Inc.
MRNA 212.04 (23.06.2021) -4.21 %
Novartis AG
NVS 92.39 (23.06.2021) -0.79 %
Novavax, Inc.
NVAX 192.24 (23.06.2021) -1.10 %
ObsEva SA
OBSV 3.01 (23.06.2021) 2.38 %
OrganiGram Holdings Inc.
OGI 3.07 (24.06.2021) 3.37 %
Pfizer Inc.
PFE 39.19 (24.06.2021) 0.36 %
Regeneron Pharmaceuticals, Inc.
REGN 544.45 (24.06.2021) 2.77 %
Sanofi
SNY 52.08 (23.06.2021) -0.42 %
Schrodinger, Inc.
SDGR 78.46 (24.06.2021) 2.07 %
Senseonics Holdings, Inc.
SENS 3.59 (23.06.2021) 3.16 %
Sorrento Therapeutics, Inc.
SRNE 9.04 (23.06.2021) 1.23 %
Stryker Corp.
SYK 261.39 (24.06.2021) -0.48 %
Sundial Growers Inc.
SNDL 1 (24.06.2021) 0.00 %
Teva Pharmaceutical Industries Lim. (TEVA)
TEVA 10.42 (24.06.2021) 2.16 %
Thermo Fisher Scientific Inc.
TMO 495.36 (24.06.2021) 0.27 %
Tilray, Inc.
TLRY 18.26 (24.06.2021) 3.69 %
UnitedHealth Group, Inc.
UNH 398.87 (24.06.2021) 0.84 %
Veeva Systems Inc.
VEEV 312 (24.06.2021) 0.28 %
Zomedica Corp.
ZOM 0.8401 (24.06.2021) -0.88 %
Zynerba Pharmaceuticals, Inc.
ZYNE 5.77 (24.06.2021) 3.59 %


Denial of responsibility:

The portal leoprophet.com is not responsible for the loss of your money as a result of your use of the information contained on the site, including data, quotes, charts and forecasts. Operations in the stock, foreign exchange and commodity markets involve a high level of risk, and you are solely responsible for your operations. Only speculate with money that you can afford to lose. All prices and forecasts for stocks, indices, futures are indicative and should not be trade dependent. The portal is not responsible for any losses that you may incur as a result of using this data.